Inhibrx Biosciences Statistics
Total Valuation
INBX has a market cap or net worth of $179.50 million. The enterprise value is $66.54 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | May 30, 2024 |
Share Statistics
INBX has 14.48 million shares outstanding. The number of shares has increased by 23.83% in one year.
| Current Share Class | 14.48M |
| Shares Outstanding | 14.48M |
| Shares Change (YoY) | +23.83% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.02% |
| Owned by Institutions (%) | 43.68% |
| Float | 7.71M |
Valuation Ratios
The trailing PE ratio is 0.11.
| PE Ratio | 0.11 |
| Forward PE | n/a |
| PS Ratio | 882.67 |
| Forward PS | n/a |
| PB Ratio | 1.84 |
| P/TBV Ratio | 1.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.04 |
| EV / Sales | 332.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.12, with a Debt / Equity ratio of 1.13.
| Current Ratio | 5.12 |
| Quick Ratio | 4.97 |
| Debt / Equity | 1.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.88 |
Financial Efficiency
Return on equity (ROE) is 4,118.34% and return on invested capital (ROIC) is -150.65%.
| Return on Equity (ROE) | 4,118.34% |
| Return on Assets (ROA) | -107.28% |
| Return on Invested Capital (ROIC) | -150.65% |
| Return on Capital Employed (ROCE) | -116.82% |
| Revenue Per Employee | $1,242 |
| Profits Per Employee | $10.70M |
| Employee Count | 161 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 39.39 |
Taxes
In the past 12 months, INBX has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | 0.00% |
Stock Price Statistics
| Beta (5Y) | 2.88 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 12.73 |
| 200-Day Moving Average | 14.01 |
| Relative Strength Index (RSI) | 53.73 |
| Average Volume (20 Days) | 95,054 |
Short Selling Information
The latest short interest is 729,920, so 5.04% of the outstanding shares have been sold short.
| Short Interest | 729,920 |
| Short Previous Month | 757,291 |
| Short % of Shares Out | 5.04% |
| Short % of Float | 9.46% |
| Short Ratio (days to cover) | 5.24 |
Income Statement
In the last 12 months, INBX had revenue of $200,000 and earned $1.72 billion in profits. Earnings per share was $111.58.
| Revenue | 200,000 |
| Gross Profit | -200.61M |
| Operating Income | -232.46M |
| Pretax Income | n/a |
| Net Income | 1.72B |
| EBITDA | -229.86M |
| EBIT | -232.46M |
| Earnings Per Share (EPS) | $111.58 |
Full Income StatementBalance Sheet
The company has $216.52 million in cash and $106.53 million in debt, giving a net cash position of $109.99 million or $7.60 per share.
| Cash & Cash Equivalents | 216.52M |
| Total Debt | 106.53M |
| Net Cash | 109.99M |
| Net Cash Per Share | $7.60 |
| Equity (Book Value) | 94.44M |
| Book Value Per Share | 6.52 |
| Working Capital | 179.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$167.25 million and capital expenditures -$1.50 million, giving a free cash flow of -$168.75 million.
| Operating Cash Flow | -167.25M |
| Capital Expenditures | -1.50M |
| Free Cash Flow | -168.75M |
| FCF Per Share | -$11.66 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -116,231.50% |
| Pretax Margin | 861,486.50% |
| Profit Margin | 861,485.50% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |